Article
A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Frontiers in immunology - 1 Jan 2021
Sun Yuhan, Sedgwick Alexander James, Palarasah Yaseelan, Mangiola Stefano, Barrow Alexander David
Abstract excerpt
The binding of platelet-derived growth factor D (PDGF-DD) to the NKp44 receptor activates a distinct transcriptional program in primary IL-2 expanded human natural killer (NK) cells. We were interested in knowing if the PDGF-DD-NKp44 pathway of NK cell activation might play a clinically relevant role in anti-tumor immunity. In order to address this question, we determined transcriptional signatures unique to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
